Earnings

Hims & Hers (HIMS) Q1 earnings 2025

Shares of Hims & Hers Health fell in extended trading on Monday after the company reported first-quarter earnings that beat analysts' expectations but offered weaker-than-expected guidance.Here's how the company did based on average analysts' estimates compiled by LSEG:Earnings per share: 20 cents vs. 12 centsRevenue: $586 million vs. $538...

Earnings

Palantir (PLTR) Q1 earnings report 2025

Alex Karp, chief executive officer of Palantir Technologies Inc., speaks during the AIPCon conference in Palo Alto, California, US, on March 13, 2025.David Paul Morris | Bloomberg | Getty ImagesPalantir boosted its revenue guidance Monday as the artificial intelligence software company saw commercial and government revenue boom.Shares fell about...

Earnings

Takeaways from Palantir CEO Alex Karp’s shareholder letter

Alex Karp, CEO of Palantir Technologies, speaks on a panel titled Power, Purpose, and the New American Century at the Hill and Valley Forum at the U.S. Capitol on April 30, 2025 in Washington, DC. Kevin Dietsch | Getty ImagesPalantir CEO Alex Karp offered up another batch of colorful...

Market Insider

Stocks making the biggest moves after hours: PLTR, F, MAT, CLX

Check out the companies making headlines in extended trading. Palantir Technologies — Shares dropped nearly 7% after the defense tech company reported first-quarter earnings that were in line with Wall Street's expectations. Adjusted earnings of 13 cents per share came in-line with the consensus estimate, per LSEG. Palantir reported...

Market Insider

BRK, SKX, TSN, NFLX and more

Check out the companies making headlines in midday trading: Berkshire Hathaway — Warren Buffett's conglomerate saw shares drop more than 4%, retreating from record highs reached on Friday. Monday's sell-off came after the 94-year-old Buffett announced his intention to step down as CEO. The board voted unanimously on Sunday...

Earnings

Ford Motor (F) earnings Q1 2025

The Ford display is seen at the New York International Auto Show on April 16, 2025.Danielle DeVries | CNBCDETROIT – Ford Motor is set to report its first-quarter earnings after the markets close Monday, but investor focus is expected to be more on the automaker's 2025 guidance and impact...

Buffet Watch

Warren Buffett’s return tally after 60 years: 5,502,284%

Warren Buffett and Greg Abel walkthrough the Berkshire Hathaway Annual Shareholders Meeting in Omaha, Nebraska on May 3, 2025. David A. Grogen | CNBC When Warren Buffett relinquishes the CEO title at Berkshire Hathaway, he'll leave investors with decades of outsized returns.Buffett shocked the investing world on Saturday with...

Market Insider

Stocks making the biggest moves premarket: HHH, SUN, NFLX

Check out the companies making headlines before the bell. Berkshire Hathaway — Warren Buffett's conglomerate saw shares fall more than 1% in premarket after hitting a record high Friday. The decline came after Berkshire's operating earnings fell 14% in the first quarter , driven by a 48.6% plunge in...

Popular Posts

Featured Posts

Featured Author

Gregg Greenberg spent 14 years as a journalist at TheStreet.com where he wrote the highly popular column "The 5 Dumbest Things on Wall Street This Week". His work has appeared in magazines ranging from Glamour to ESPN the Magazine, and on humor sites such as Points in Case.

Fintech Review

With years of experience dissecting and evaluating the evolving fintech landscape, Fintech Review has become a trusted name in providing insightful, comprehensive, and unbiased reviews of tech-related financial products and services. From the latest advancements in blockchain and cryptocurrencies to cutting-edge payment platforms, robo-advisors, and beyond, Fintech Review keeps a pulse on the innovations that are redefining the financial industry.

Metronome’s usage-based billing software finds hit in AI as the startup raises $43M in fresh capital

Metronome, a startup that helps software companies offer usage-based billing, has raised $43 million in a Series B funding round led by NEA. Existing backers Andreessen Horowitz and General Catalyst also participated in the financing, which brings its total amount raised to over $78 million since its 2019 inception.  Founded by...

Biogen drops Alzheimer’s drug Aduhelm to focus on Leqembi, others

The Biogen headquarters in Cambridge, Massachusetts, on Oct. 24, 2023.Vanessa Leroy | Bloomberg | Getty ImagesBiogen on Wednesday said it will discontinue the sale and development of its older and highly controversial Alzheimer's drug Aduhelm to refocus the company's efforts to treat the memory-robbing disease. The biotech company will focus...